Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2007; 13(32): 4394-4397
Published online Aug 28, 2007. doi: 10.3748/wjg.v13.i32.4394
Published online Aug 28, 2007. doi: 10.3748/wjg.v13.i32.4394
Figure 1 Clinical course of peg-interferon (peg-IFN) plus ribavirin therapy for hepatitis C virus infection.
ALT: Alanine aminotransferase; AST: asparate aminotransferase; T-Bil: total bilirubin.
Figure 2 Clinical course of fulminant hepatic failure.
PSL: prednisolone; mPSL:methylprednisolone; UA: uric acid; PT: prothrombin time; FFP: fresh frozen plasma; AT-3: antithrombin III.
Figure 3 A, B: Abdominal CT at the onset of hepatic encephalopathy; C, D: Enhanced abdominal MRI.
Figure 4 Liver biopsy showing interface hepatitis with infiltration of plasma cells and rosette formations.
A, C: Hepatoxyline-Eosin staining; B: Elastica-Masson staining.
- Citation: Kogure T, Ueno Y, Fukushima K, Nagasaki F, Inoue J, Kakazu E, Matsuda Y, Kido O, Nakagome Y, Kimura O, Obara N, Wakui Y, Iwasaki T, Shimosegawa T. Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment. World J Gastroenterol 2007; 13(32): 4394-4397
- URL: https://www.wjgnet.com/1007-9327/full/v13/i32/4394.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i32.4394